Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00993694 · ClinicalTrials.gov registry record
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 41
- Enrollment target
NCT00993694 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 41 participants.
The verdict
NCT00993694 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about how often methemoglobinemia occurs in young patients receiving dapsone for hematologic cancer or aplastic anemia may help doctors learn more about the disease and plan the best treatment. PURPOSE: This research study is looking at methemoglobinemia in young patients with hematologic cancer or aplastic anemia treated with dapsone.
Interventions
- OTHER medical chart review
- DRUG chemotherapy
- PROCEDURE assessment of therapy complications
- DRUG dapsone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00993694
The ClinicalTrials.gov registry entry for NCT00993694 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which medical chart review is the first listed.
NCT00993694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00993694 about?
NCT00993694 is a clinical study titled "Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone". RATIONALE: Gathering information about how often methemoglobinemia occurs in young patients receiving dapsone for hematologic cancer or aplastic anemia may help doctors learn more about the disease and plan the best treatment. PURPOSE: This research study is looking at methemoglobinemia in young pa...
What is the current status of trial NCT00993694?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2009-01. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00993694?
The interventions under investigation include: medical chart review (OTHER), chemotherapy (DRUG), assessment of therapy complications (PROCEDURE), dapsone (DRUG).
Who is sponsoring clinical trial NCT00993694?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.